Chinese shares are lower early in the session, with the benchmark Shanghai Composite Index declining 0.5% to 3269.64. The Shenzhen Composite Index drops 0.2% and the ChiNext Price Index is 1.0% lower. Investors are waiting for more details on China's planned fiscal stimulus package
Chinese equities have surged due to recent dovish measures by the PBoC, creating unique market dynamics and opportunities for investors. China has major looming economic issues thanks to its malinvestment and demographics.
The PBoC's dovish measures have led to a surge in Chinese equities. There are several unusual characteristics of the current market environment for FXI.
The Chinese stock market indices have reversed higher in striking fashion. But this has all occurred after the Chinese government announced a robust stimulus package.
Tim Edwards, global head of index investment strategy at S&P Dow Jones Indices, discusses volatility in China and valuation trends.
John Rutledge, Safanad chief investment strategist, joins 'Closing Bell Overtime' to talk China's market pullback and how U.S. investors should navigate it.
Chinese stocks cratered on Tuesday. Stock Strategist Andrew Rocco explains how the fundamentals and technicals suggest that the pullback is likely a buying opportunity rather than a top.
ETFs across various categories pulled in $28.2 billion in capital last week, with U.S. equity ETFs leading the way.
Chinese shares soared to two-year highs on Tuesday, pushing a blistering rally even further as trade resumed after a week-long holiday and investors bet on stimulus supporting the economy.
China's equity markets will keep rising after business in the mainland resumes following the Golden Week break, analysts predicted. But they face the risk of "an ugly reversal in sentiment into 2025," said Shehzad Qazi, chief operating officer at China Beige Book International.
Whether you caught the move in Chinese stocks or not, it is worth reviewing. Stock Strategist Andrew Rocco explains how valuations, smart money buying, and a liquidity injection drove the move.
I highlighted iShares China Large-Cap ETF as a contrarian investment on June 20, 2024, citing Charlie Munger's belief in Chinese stocks' long-term value despite bearish trends. China's late September stimulus, including interest rate cuts and liquidity injections, spurred a sharp rally in the FXI ETF, reaching a new 2024 high. FXI remains attractive with a low P/E ratio compared to U.S. ETFs, but geopolitical risks with the U.S. and Taiwan persist.